CD8A and melanoma: To this point, immunization of tumor-bearing mice with MSR1 gene-silenced BMDC improved vaccine-induced CD8+ T cell responses against multiple melanoma antigens and enhanced immunologic control of established B16 melanomas in both subcutaneous and lung metastasis models (182).